=== SEC Form 4 — Statement of Changes in Beneficial Ownership ===
Document Type: 4
Period of Report: 2026-01-07
10b5-1 Pre-arranged Plan: Yes
--- Issuer ---
Name: Guardant Health, Inc. (GH)
CIK: 0001576280
--- Reporting Owner ---
Name: Monroe Terilyn J.
CIK: 0001652956
Role: Officer (Chief People Officer)
--- Non-Derivative Transactions ---
[Transaction #1]
Security: Common Stock
Date: 2026-01-07 | Code: S (Open market sale)
Shares: -6,311 | Price: $111.75
Total Value: $705,267.50
Shares Owned After: 24,710 | Ownership: D (Direct)
Footnotes:
[F1] Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $111.230 to $112.175. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.
[Transaction #2]
Security: Common Stock
Date: 2026-01-07 | Code: S (Open market sale)
Shares: -3,632 | Price: $112.62
Total Value: $409,029.30
Shares Owned After: 21,078 | Ownership: D (Direct)
Footnotes:
[F2] Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $112.260 to $113.250. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.
[Transaction #3]
Security: Common Stock
Date: 2026-01-07 | Code: S (Open market sale)
Shares: -88 | Price: $113.44
Total Value: $9,982.69
Shares Owned After: 20,990 | Ownership: D (Direct)
Footnotes:
[F3] Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $113.410 to $113.490. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.
--- Footnotes (Complete Index) ---
F1: Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $111.230 to $112.175. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.
F2: Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $112.260 to $113.250. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.
F3: Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $113.410 to $113.490. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.
--- Signature ---
/s/ /s/ John G. Saia, as attorney-in-fact for Tarilyn J. Monroe (2026-01-09)
